[Correcting posthypoxic damage of myocardium in newborns with cerebral ischemia]

Area of Science:

• Neonatal cardiology
• Pediatric neurology
• Cardiovascular research

Context:

• Post-hypoxic myocardial lesions in newborns often accompany cerebral ischemia.
• Standard treatment may not fully address myocardial dysfunction and metabolic deficits.
• Early intervention is crucial for improving outcomes in affected neonates.

Purpose:

• To evaluate the efficacy of cytoflavin infusions as an adjunct to standard therapy for newborns with post-hypoxic myocardial lesions and cerebral ischemia.
• To assess the impact of cytoflavin on myocardial function, metabolic status, and electrical stability.
• To compare the recovery dynamics between neonates receiving cytoflavin and those receiving standard treatment alone.

Summary:

• A multicenter trial included 30 newborns with post-hypoxic myocardial lesions and I-II degree cerebral ischemia.
• Cytoflavin infusions were added to standard complex treatment.
• Significant improvements were observed in pump and contractile myocardial functions, elimination of hyperenzymemia, hypoxia, electrical instability, decreased energetic deficit, and repolarization changes within 5 days and 6 months follow-up.

Impact:

• Cytoflavin accelerates the recovery of pump and contractile myocardial functions in neonates with hypoxic-ischemic injury.
• The treatment effectively mitigates biochemical markers of myocardial damage and instability.
• Early administration of cytoflavin contributes to improved long-term cardiac outcomes in vulnerable newborns.